The Dark Secrets of Johnson & Johnson.” Gardiner Harris, a former pharmaceutical reporter for The New York Times and a reporter for The Wall Street Journal, effectively explains the legal battles ...

Mar Vista U.S. Quality Select Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its Q1 2025 investor ...

National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, ...

Corporate America is counting the cost of Donald Trump’s trade war, with executives warning of escalating expenditures, gummed-up supply chains and a hit to the world’s largest economy.

Nokia could expand its U.S. manufacturing capabilities as a way to counter possible impacts of Trump's tariffs, according to ...

Trump's landmark period is like no other in modern presidential politics, leaving businesses and investors in a state of ...

President Trump this week backed away from his threats to remove Federal Reserve Chair Jerome Powell. That could end up ...

Elon Musk says he’s going back to Tesla. The question now is whether or not it’s too late to reverse the damage that’s been done.

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

The Dow Jones Industrial Average sank more than 1,000 points, the yield on a 10-year Treasury note rose to 4.89 percent, and ...

It does make laugh (bitterly) that Wall Street, and the larger world of finance, is just catching on to what many of us knew ...